TrialNutrients2013

Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans.

Heidrun Mehling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.